---
figid: PMC9416627__pharmaceutics-14-01590-g003
pmcid: PMC9416627
image_filename: pharmaceutics-14-01590-g003.jpg
figure_link: /pmc/articles/PMC9416627/figure/pharmaceutics-14-01590-f003/
number: Figure 3
figure_title: ''
caption: Inhibition of GPI biosynthesis pathway in Leishmania by different repurposed
  and/or potential drug candidates.
article_title: 'Metabolic Pathways of Leishmania Parasite: Source of Pertinent Drug
  Targets and Potent Drug Candidates.'
citation: Surbhi Jain, et al. Pharmaceutics. 2022 Aug;14(8):1590.
year: '2022'

doi: 10.3390/pharmaceutics14081590
journal_title: Pharmaceutics
journal_nlm_ta: Pharmaceutics
publisher_name: MDPI

keywords:
- Leishmania
- human pathogen
- targeting metabolic pathways
- repurposed drugs
- new anti-leishmanials

---
